![](/img/cover-not-exists.png)
Mavrilimumab for severe COVID-19
Pourhoseingholi, Mohamad Amin, Shojaee, Sajad, Ashtari, SaraVolume:
2
Journal:
The Lancet Rheumatology
DOI:
10.1016/S2665-9913(20)30307-6
Date:
November, 2020
File:
PDF, 52 KB
2020